Serina Therapeutics, Inc.

Serina Therapeutics (SER) has registered zero cyber incidents and zero red-flag 8-K filings in our 90-day monitoring window, indicating no acute governance events in the recent period. However, absence of signal in a short window does not establish absence of risk; the full Report extends analysis to 12 months of filings, calculates dilution risk scores based on financing history, and surfaces AI-detected patterns in capital raises and officer movements. The full $49 Report adds quantified dilution exposure, detailed 8-K context, and financing trajectory analysis to contextualize what stability in the near term may mask longer-term.